Octavio Ballesta-López

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Venues

Expert review of clinical pharmacology

Leukemia & lymphoma

Annals of hematology

Future oncology (London, England)

Hospital Universitari i Politècnic La Fe

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Universitari i Politècnic La Fe

Spain

Clinical Trials Pharmacist :: Pharmacy

Hospital Universitari i Politècnic La Fe

Spain

Resident :: Pharmacy

Publications

Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape. Expert review of clinical pharmacology 16 (2) (2023)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape. Expert review of clinical pharmacology (2023)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape. Expert review of clinical pharmacology (2023)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape. Expert review of clinical pharmacology 16 (2) (2023)
Antonio Solana-Altabella, Octavio Ballesta-López, Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Pau Montesinos
Emerging FLT3 inhibitors for the treatment of acute myeloid leukemia. Expert opinion on emerging drugs 27 (1) (2022)
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, Blanca Boluda, Isabel Cano, Evelyn Acuña-Cruz, Rebeca Rodríguez-Veiga, Laura Torres-Miñana, Claudia Sargas, Miguel Angel Sanz, Carmela Borrell-García, Eduardo López-Briz, José Luis Poveda-Andrés, Javier de la Rubia, Pau Montesinos, David Martínez-Cuadrón
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study. Cancers 14 (8) (2022)
Blanca Boluda, Antonio Solana-Altabella, Isabel Cano, Evelyn Acuña-Cruz, Rebeca Rodríguez-Veiga, Octavio Ballesta-López, Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Ines Gómez, Pilar Solves, Ignacio Lorenzo, Jose Luis Piñana, Jaime Sanz, Manuel Guerreiro, Juan Montoro Gómez, Alvaro Díaz-González, Javier Marco, Albert Blanco, Miguel Angel Sanz, Pau Montesinos
Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain. Journal of clinical apheresis 36 (4) (2021)
Ruben Iglesias Gomez, Raúl Méndez, Tomás Palanques-Pastor, Octavio Ballesta-López, Conxa Borrás Almenar, Juan Eduardo Megías-Vericat, Eduardo López-Briz, Isabel Font-Noguera, Rosario Menéndez Villanueva, José Andrés Román Iborra, José Luis Poveda Andrés
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients. European journal of hospital pharmacy : science and practice (2021)
Octavio Ballesta-López, Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Pau Montesinos
Gilteritinib use in the treatment of relapsed or refractory acute myeloid leukemia with a FLT3 mutation. Future oncology (London, England) 17 (2) (2020)
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, María José Herrero, Rebeca Rodríguez-Veiga, Antonio Solana-Altabella, Blanca Boluda, Octavio Ballesta-López, Isabel Cano, Evelyn Acuña-Cruz, José Cervera, José Luis Poveda, Miguel Angel Sanz, Salvador F Aliño, Pau Montesinos
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia. Leukemia & lymphoma 62 (3) (2020)
Octavio Ballesta-López, Asunción Albert-Marí, Carmela Borrell-García, Marcos Melián-Sosa, Carmen Salvador-Coloma, Ana Santaballa-Bertrán, José Luis Poveda-Andrés
Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (2) (2020)
Juan Eduardo Megías-Vericat, Antonio Solana-Altabella, Octavio Ballesta-López, David Martínez-Cuadrón, Pau Montesinos
Drug-drug interactions of newly approved small molecule inhibitors for acute myeloid leukemia. Annals of hematology 99 (9) (2020)

Octavio Ballesta-López.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Octavio Ballesta-López